United Kingdom-based CBD company Green Active is donating some profits to a Scottish boy suffering from Doose Syndrome, a severe form of epilepsy, as the National Health Service continues denying to cover the costs of cannabis-based medications, the Daily Record reports.
Eight-year-old Murray Gray was diagnosed with the disease in 2017 and had up to 12 seizures a day, eventually ending up in a vegetative state in the hospital. His mother, Karen, said he has been seizure-free for 15 months after he started taking Bedrolite and Bedica – which are approved for use in the UK – but the regimen runs £1,400 per month and the NHS refuses to write a prescription which would provide it to the family for free.
Jo Devall, co-owner of Green Active with his partner Melissa Lopes Correa, said he learned about the boy via Twitter and his story “resonated” with him. All sales using the code FORMURRAY will be donated to Gray’s family and customers who use that code will also get 10 percent off.
He explained that funding the boy’s medicine wouldn’t bankrupt the company because they will still take their operating costs “but all the profit after that will go to Murray.”
Karen called the plan “absolutely brilliant” even though neither she nor GreenActive knew exactly how much the campaign might raise. She criticized the NHS inaction since Bedrolite and Bedica were added to the service two years ago.
“We should have a prescription for this rather than having to rely on our friends, family and the kindness of companies to pay for it,” she said.
According to pro-medical cannabis group End Our Pain, the NHS has issued just three prescriptions for medical cannabis oil since it was legalized for use on the national health care plan two years ago.
Jo Devall和他的伴侣Melissa Lopes Correa是Green Active的共同拥有者，他说他是通过推特得知这个男孩的，他的故事引起了他的“共鸣”。所有使用FORMURRAY代码的销售额都将捐给Gray的家人，使用该代码的顾客还将获得10%的折扣。